Skip to content
  • Migraine
  • Our Science
    • POD Technology
    • Publications & Presentations
    • Meetings
    • Clinical Trials
    • Intellectual Property
  • Contact
  • Migraine
  • Our Science
    • POD Technology
    • Publications & Presentations
    • Meetings
    • Clinical Trials
    • Intellectual Property
  • Contact

Leadership

  • Impel History
  • Leadership
  • Board of Directors
  • Scientific Advisors
  • Collaborations

Leadership

Leonard S. Paolillo
Leonard S. Paolillo

Interim President & Chief Executive Officer

John-Hoekman
John Hoekman

Chief Technology & Development Officer

Scott-Youmans
Scott Youmans

Senior VP of Technical Operations

Rigo Canal
Rigo Canal

VP of Commercial Operations & Analytics

Sarah Wille
Sarah Wille

VP of Human Resources

CONNECT WITH US
Icon Twitter link to Twitter Icon LinkedIn link to linkedIn
Impel Pharmaceuticals is a commercial-stage pharmaceutical company developing first-in-class intranasal drug treatments for disorders with high unmet medical needs.

IMPEL, POD, Trudhesa, Trudhesa DIRECT, and the Impel and Trudhesa Logos are trademarks of Impel Pharmaceuticals. Other trademarks are the property of the respective owner(s).

Impel Pharmaceuticals LLC

Privacy Policy

Terms of Service

Social Media Policy

CA Disclosure

© 2025 Impel Pharmaceuticals LLC. All Rights Reserved

Privacy Policy

Terms of Service

Social Media Policy

CA Disclosure